Trademark: 78729279
Word
MOLECULARINSIGHT PHARMACEUTICALS
Status Date
Monday, April 26, 2010
Filing Date
Friday, October 7, 2005
Published for Opposition
Tuesday, January 2, 2007
Abandoned Date
Monday, April 26, 2010
5 Cardiovascular pharmaceuticals
The colors blue and pink are claimed as a feature of the mark.
The mark consists of the word "molecularinsight" in lowercase letters centered over the word "pharmaceuticals", which is also in lowercase letters. The words "molecular" and "pharmaceuticals" appear in blue. The word "insight" appears in pink. Three pink colored and stylized oval disks of increasing size appear to the right of the lettering.
"PHARMACEUTICALS"
MOLECULAR INSIGHT PHARMACEUTICALS
Jun 1, 2011
Assignment Of Ownership Not Updated Automatically
Apr 26, 2010
Abandonment Notice Mailed - No Use Statement Filed
Apr 26, 2010
Abandonment - No Use Statement Filed
Sep 10, 2009
Extension 5 Granted
Sep 8, 2009
Extension 5 Filed
Sep 8, 2009
Teas Extension Received
Apr 7, 2009
Extension 4 Granted
Mar 24, 2009
Extension 4 Filed
Apr 7, 2009
Case Assigned To Intent To Use Paralegal
Mar 24, 2009
Teas Extension Received
Sep 11, 2008
Extension 3 Granted
Sep 11, 2008
Extension 3 Filed
Sep 11, 2008
Teas Extension Received
Mar 17, 2008
Extension 2 Granted
Mar 17, 2008
Extension 2 Filed
Mar 17, 2008
Teas Extension Received
May 7, 2007
Extension 1 Granted
May 7, 2007
Extension 1 Filed
May 7, 2007
Teas Extension Received
Mar 27, 2007
Noa Mailed - Sou Required From Applicant
Jan 2, 2007
Published For Opposition
Dec 13, 2006
Notice Of Publication
Nov 9, 2006
Law Office Publication Review Completed
Nov 3, 2006
Assigned To Lie
Oct 30, 2006
Approved For Pub - Principal Register
Oct 10, 2006
Teas/Email Correspondence Entered
Oct 9, 2006
Correspondence Received In Law Office
Oct 9, 2006
Teas Response To Office Action Received
Apr 12, 2006
Non-Final Action E-Mailed
Apr 12, 2006
Non-Final Action Written
Apr 11, 2006
Assigned To Examiner
Oct 12, 2005
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
